Skyrizi 180 MG/1.2 ML on-body 1.2ML
Ended Awarded Last action
- Contract number
- SPE2DR26F96F6
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $12,467
Award facts
- Contract value 100% obligated
- $12,467.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
AmerisourceBergen Drug Corp received a $12,467 firm fixed-price delivery order from the Defense Logistics Agency (DLA) on December 30, 2025, for the supply of SKYRIZI 180 mg/1.2 mL on-body injector units. The order is scheduled for completion by January 22, 2026, and will be fulfilled from the company's facility in Conshohocken, Pennsylvania. This delivery order represents a competitively awarded, non-set-aside procurement with no small business or socioeconomic restrictions applied. The award is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at $999,999,999 through December 2026, which serves as a global pharmaceutical support vehicle for military healthcare systems.
AmerisourceBergen Drug Corp functions as a critical pharmaceutical distributor for federal medical procurement, particularly supporting the Defense Health Agency and military healthcare programs. SKYRIZI is a specialty biologic medication used in dermatological treatment, reflecting the company's established role in delivering brand-name and specialized pharmaceutical products across multiple therapeutic domains. The DLA's Medical Supply Chain relies on AmerisourceBergen's comprehensive portfolio to provision pharmaceuticals, vaccines, and medical devices to military and veteran healthcare systems. This award demonstrates the company's continued capability to meet federal procurement requirements for specialized medical commodities through its established infrastructure and logistics capabilities.
Quick answers
Who was awarded contract SPE2DR26F96F6?
SPE2DR26F96F6 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 30, 2025.
How much is contract SPE2DR26F96F6 worth?
The government has obligated $12,467 on SPE2DR26F96F6.
Is contract SPE2DR26F96F6 an order under another contract?
Yes. SPE2DR26F96F6 is a delivery order under SPE2DR25D3505, an indefinite delivery contract.
Was contract SPE2DR26F96F6 competed?
The extent of competition for SPE2DR26F96F6 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award